1 Reason I'd Buy Vertex Pharmaceuticals Stock and Never Sell

Vertex Pharmaceuticals (NASDAQ: VRTX) is a great example of a biotech success story. The company has developed strength in a specialty area and, thanks to that, has delivered a track record of revenue and profit growth over the past decade. This is in cystic fibrosis (CF), an area where Vertex has secured leadership.On top of that, in recent years, Vertex has proven that it has what it takes to expand into other treatment areas. The company won approval for gene editing treatment Casgevy for blood disorders and, most recently, for Journavx, a non-opioid drug for pain management.Vertex makes a great investment for many reasons, but for one reason in particular, I would buy this stock and never sell.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool